- Tytuł:
- INFLAMMATORY MARKERS AND NEUROPEPTIDES CHARACTERISTIC OF PARKINSON’S DISEASE AND THEIR RESPONSE TO VISUALIZATION AND SUGGESTION BASED MIND-BODY THERAPY
- Autorzy:
-
Ostapiuk-Karolczuk, Joanna
Kasperska, Anna
Botwina, Ryszard - Powiązania:
- https://bibliotekanauki.pl/articles/2137791.pdf
- Data publikacji:
- 2017-12-23
- Wydawca:
- Fundacja Edukacji Medycznej, Promocji Zdrowia, Sztuki i Kultury Ars Medica
- Tematy:
-
mind-body therapy
visualization
inflammation
dopamine
BDNF Parkinson`s disease - Opis:
- Progress in elucidating neuroimmune connections has created new opportunities for improving the treatment of Parkinson’s disease (PD). In recent years, mind-body therapies have been shown to have positive effects on the immune and nervous systems, but interactions at the molecular level have not been tested. Thus, the main aim of the present study was to investigate the effects of therapy based on visualization and suggestion on the concentrations of IL-6, CRP, DA, BDNF, CoQ10, and TAC in patients with advanced PD. Eight patients with PD and 8 elderly healthy men (control group) were enrolled in the study. The therapy lasted 19 days and consisted of three parts: individual sessions with the therapist, mixed (therapist and audio-file), and self-training (audio-file). Blood samples were taken before training and at the end of each part. The expected changes in the investigated markers was observed during therapy: the serum concentration of IL-6 and CRP decreased, whereas DA and BDNF increased, however, this change was observed only after the first part of intervention when the therapy was conducted by the therapist. In the subsequent stages, the levels returned to the baseline. Noteworthy, after the therapy, we observed a significant increase in the motor and intellectual skills of the PD patients. No such changes were observed in the control group. Mind-body therapy based on visualization and suggestions aimed at changing the concentrations of signaling molecules, which are crucial in the development or treatment of PD, may be an effective element in supporting pharmacological therapy.
- Źródło:
-
Acta Neuropsychologica; 2017, 15(4); 443-456
1730-7503
2084-4298 - Pojawia się w:
- Acta Neuropsychologica
- Dostawca treści:
- Biblioteka Nauki
Artykuł